192945-49-6 Usage
General Description
4-(1H)indazole carboxylic acid methyl ester is a chemical compound with the molecular formula C9H8N2O2. It is a methyl ester derivative of indazole carboxylic acid, which is a heterocyclic aromatic compound. This chemical is commonly used in organic synthesis as a reagent or precursor for the preparation of various indazole derivatives. It has also been investigated for potential pharmaceutical applications, particularly in the development of new drugs with therapeutic properties. Additionally, 4-(1H)indazole carboxylic acid methyl ester has been studied for its role in the field of medicinal chemistry and as an intermediate in the synthesis of bioactive compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 192945-49-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,2,9,4 and 5 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 192945-49:
(8*1)+(7*9)+(6*2)+(5*9)+(4*4)+(3*5)+(2*4)+(1*9)=176
176 % 10 = 6
So 192945-49-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H8N2O2/c1-13-9(12)6-3-2-4-8-7(6)5-10-11-8/h2-5H,1H3,(H,10,11)
192945-49-6Relevant articles and documents
INDAZOLE AND PYRAZOLOPYRIDINE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS
-
Page/Page column 42-43, (2011/05/06)
Diclosed are CCRl receptor antagonists of the formula (I), wherein X is nitrogen or, C-R2; Ar1 is carbocycle, heteroaryl or heterocyclyl each optionally substituted by one to three Ra; Ar2 is carbocycle, heteroaryl or heterocyclyl, each optionally substituted by one to three Rb; Cyclic G is carbocycle, or heterocyclyl each optionally substituted by one to two R8; R1 is hydrogen, C1-6 alkyl or C 1-6 alkoxyC1-6 alkyl. Also disclosed are compositions, methods of making and using compounds of the formula (I).
SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE
-
Page/Page column 127-128, (2010/11/27)
Compounds are provided that are modulators of the C5a receptor. The compounds are substituted dihydropyridines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of C5a receptors.
